2022
DOI: 10.1039/d2md00097k
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the effect of a cell penetrating peptide (TAT) towards tailoring the targeting efficacy and tumor uptake of porphyrin

Abstract: Cell penetrating peptides (CPPs) are known to possess the unique capacity to penetrate biological membrane and translocate various molecules into the cells. Therefore, porphyrin-CPP conjugates could be envisaged to boost...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…Although porphyrins have good tumor-targeting potential and optimal optical properties, their nonspecific uptake significantly weighs down their potential for clinical applications. To circumvent this, the use of various secondary targeting vectors, such as peptides and antibodies, has been reported in the literature. , In the present work, a peptide, namely nuclear cell localization signal (NLS), was utilized with the aim of enhancing the target accumulation/uptake as well as maneuvering the pharmacokinetics of an in-house synthesized porphyrin derivative. As NLS [PKKKRKV] is a hydrophilic amino acid chain, a relatively lipophilic porphyrin derivative ( p -methoxyphenyl as a meso substituent) was chosen for the preparation peptide-porphyrin conjugate so as to strike a balance between lipophilicity and hydrophilicity to get the desirable in vivo outcome.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although porphyrins have good tumor-targeting potential and optimal optical properties, their nonspecific uptake significantly weighs down their potential for clinical applications. To circumvent this, the use of various secondary targeting vectors, such as peptides and antibodies, has been reported in the literature. , In the present work, a peptide, namely nuclear cell localization signal (NLS), was utilized with the aim of enhancing the target accumulation/uptake as well as maneuvering the pharmacokinetics of an in-house synthesized porphyrin derivative. As NLS [PKKKRKV] is a hydrophilic amino acid chain, a relatively lipophilic porphyrin derivative ( p -methoxyphenyl as a meso substituent) was chosen for the preparation peptide-porphyrin conjugate so as to strike a balance between lipophilicity and hydrophilicity to get the desirable in vivo outcome.…”
Section: Discussionmentioning
confidence: 99%
“…The development of small molecule-based agents which target neoplastic tissues through various pathways, including passive diffusion or tumor-microenvironment-specific routes, has seen occasional success in achieving the desired in vivo outcomes . Porphyrins fall into this category and find limited clinical applications due to suboptimal tumor uptake and undesirable accumulation in nontarget organs. To address these biodistribution challenges, researchers have explored the conjugation of the porphyrins with other potential targeting molecules. One such approach involves using a nuclear localization signal (NLS) peptide sequence, which is rich in positively charged amino acids. The cationic nature of NLS facilitates the transport of molecular cargo across the nuclear membrane, potentially aiding in the cellular import of linked porphyrin derivatives. A seven amino acid sequence, namely PKKKRKV (Pro-Lys-Lys-Lys-Arg-Lys-Val), belongs to the family of NLS peptides, and like others in this family, it is well recognized by the nuclear pore complex.…”
Section: Introductionmentioning
confidence: 99%
“…Peptides are cheap and easy to synthesise; in addition, most peptides are capable of enduring harsh radiolabelling conditions 39 . Consequently, peptides have been used widely as radiopharmaceuticals 40–43 and as agents to modulate the pharmacokinetic properties radiopharmaceuticals 44–48 . The use of peptides in the development of CNS‐target radiopharmaceuticals is comparatively limited by comparison.…”
Section: Main Textmentioning
confidence: 99%
“… 39 Consequently, peptides have been used widely as radiopharmaceuticals 40 , 41 , 42 , 43 and as agents to modulate the pharmacokinetic properties radiopharmaceuticals. 44 , 45 , 46 , 47 , 48 The use of peptides in the development of CNS‐target radiopharmaceuticals is comparatively limited by comparison. In the following sections, we provide a brief overview of the use of peptides in nonradioactive therapeutic and diagnostic agents and discuss how these might be utilised in the development of novel CNS‐target radiopharmaceuticals.…”
Section: Main Textmentioning
confidence: 99%
“…Because their amphiphilicities are still maintained, they are capable of self-assembling in aqueous solution and acting as nanocarriers to deliver porphyrins and other active species in vivo . Even so, some porphyrins, such as Ce6, are inherently amphiphiles and can self-assemble to form nanoparticles without the addition of other hydrophilic tags. Different types of hydrophilic tags can endow them and their self-assembles with unique advanced functionalities, for example, long circulation duration and resistance to protein adsorption in circulation in vivo from oligo (ethylene glycol), , cells and tumors targeting from peptides and glycosyls. In addition, most of the self-assembled structures of porphyrin-hydrophilic tag amphiphiles are nanoaggregation without a bilayer membrane structure which often forms in the case of porphyrin-based lipids demonstrated by the reported documents. …”
Section: Porphyrin-based Amphiphilesmentioning
confidence: 99%